Surrozen, Inc./DE

SRZNNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$3.5M

▼ 67.4% YoY

Net Income

-$242.0M

▼ 280.8% YoY

EPS

$-32.37

▼ 49.4% YoY

Cash

$89.2M

▲ 158.2% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.